About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
16 Jul 2024
In this guest blog post, GA4GH active contributor Alex Wagner explores how “unconferences” have supported standards development for the GA4GH Genomic Knowledge Standards Work Stream. Wagner invites the community to attend the Cancer Variant Curation and Coding Unconference at the Cancer Genome Consortium (CGC) meeting this August.
By Alex Wagner, Co-Lead of the Variation Representation Specification (VRS) and Driver Project Champion of the Variant Interpretation for Cancer Consortium (VICC)
Eight years ago, a small gathering of cancer knowledgebase maintainers assembled for a working meeting at the American Association for Cancer Research (AACR) annual conference. The individuals present, representing research groups with an interest in the exchange of cancer variant knowledge, had assembled to discuss the challenges of genomic knowledge representation and the interpretation bottleneck. Through the shared experiences and ideas of that meeting, it became clear that a consortium effort was needed to understand and address the challenges of harmonizing data across publicly available cancer variant knowledgebases. These investigators went on to establish the Variant Interpretation for Cancer Consortium (VICC) to evaluate and advance the interoperability of cancer variant interpretation knowledge.
Today, the VICC is a Global Alliance for Genomics and Health (GA4GH) Driver Project, and remains dedicated to advancing the interoperability of data generated and shared across cancer knowledgebases worldwide. The ongoing research efforts of the VICC have driven development of multiple clinical standards for representing and integrating genomic evidence in cancer variant evaluation, providing a foundation for the technical standards development of the GA4GH Genomic Knowledge Standards (GKS) Work Stream. The VICC anchors standards development through collaborative activities with many partner consortia, including projects with the Cancer Genome Consortium (CGC), the Clinical Genome Resource (ClinGen) Somatic Cancer work group, the American Medical Informatics Association (AMIA), the Association for Molecular Pathology (AMP), and the Human Genome Organization (HUGO).
The VICC vision for success stems from the roots of our organization: the VICC continues to find opportunities to host focused satellite meetings in conjunction with major conferences where the community is already congregating. We co-hosted a one-day meet-up with the HemOnc.org knowledgebase ahead of the American Association for Cancer Research (AACR) Advancing Precision Medicine Drug Development meeting in 2020, and on multiple occasions with the Clinical Interpretation of Variants in Cancer (CIViC) platform and ClinGen Somatic Cancer working group ahead of the CGC annual conference.
These satellite, in-person events, typically held as “unconferences,” have facilitated the development and evaluation of significant efforts, such as oncogenicity classification standards, the VICC/ClinGen virtual molecular tumor board seminar series with the American College of Medical Genetics (ACMG), and the cross-community specification for gene fusion representation involving ClinGen, CGC, HUGO, and AMP. The wide reach of these resulting efforts, grounded in clinical laboratory practice, have provided the foundation for our contributions to GKS standards development. And since the unconference format allows us to share and select the topics of broadest value to the event participants on the day of the meeting, topics are always timely and of broad relevance to the community. These events also provide ample time to explore these topics in depth, in a format that is much more engaging than what can be accomplished on a monthly, one hour community call. As a result, these events have nucleated interdisciplinary working groups that can continue advancing clinical cancer variant interpretation standards well beyond the unconference event.
This August, VICC, ClinGen, and CIViC are hosting another Cancer Variant Curation and Coding Unconference as a pre-conference activity of the 2024 CGC annual meeting in St. Louis, Missouri, USA. As an in-person event at CGC, it enables us to engage a wider cross-section of the clinical oncology community. We will focus on identifying and exploring common areas of interest in cancer genomics and health data sharing. One potential discussion topic is the computational representation of cytogenomics data in clinical cancer practice, a crucial yet under-discussed area in GA4GH that has global relevance to clinical genomics practice. Previous unconferences have covered topics like data representation, clinical reporting, and variant curation.
The unconference provides an ideal opportunity to introduce GA4GH products and projects to a relevant audience of clinical scientists and pathologists. As with that initial meetup of GA4GH investigators at AACR that established the VICC, this unconference is an opportunity for the GA4GH Cancer Community to engage in a structured setting to identify and discuss contemporary challenges in the use of cancer community resources in clinical genomics. It is our hope that this unconference is the first of a series of such events held to facilitate engagement between GA4GH Communities of Interest (in this case, the GA4GH Cancer Community) with practicing clinical genomics communities.
Please consider joining us for this community event at the CGC 2024 Annual Meeting, taking place 4 to 7 August at the Hyatt Regency St. Louis at the Arch. Registration details can be found here. To attend the unconference on 3 August at the same venue (and I hope that you will!), indicate ‘Unconference participation’ when you register for the CGC meeting. The event agenda can be accessed here.